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Multidetector CT and MR Imaging of
Cardiac Tumors
The purpose of this article is to provide a current review of the spectrum of mul-
tidetector CT (MDCT) and MRI findings for a variety of cardiac neoplasms. In the
diagnosis of cardiac tumors, the use of MDCT and MRI can help differentiate
benign from malignant masses. Especially, the use of MDCT is advantageous in
providing anatomical information and MRI is useful for tissue characterization of
cardiac masses. Knowledge of the characteristic MRI findings of benign cardiac
tumors or thrombi can be helpful to avoid unnecessary surgical procedures.
Presurgical assessment of malignant cardiac tumors with the use of MDCT and
MRI may allow determination of the resectability of tumors and planning for the
reconstruction of cardiac chambers.
ardiac tumors have a cumulative prevalence of 0.002-0.3% as
determined from an autopsy (1). Primary cardiac neoplasms include both
benign and malignant histological types (Table 1) (2). Metastatic involve-
ment of the heart is approximately 30 times more prevalent than primary cardiac
tumors. Although primary cardiac tumors are rare and the histological types are
varied, familiarity with certain imaging features can help distinguish between benign
and malignant cardiac tumors. Up to now, transthoracic echocardiography has been
the most widely used imaging modality for the evaluation of cardiac masses.
Echocardiography is the best imaging modality to depict small masses that arise from
the cardiac valves. However, visualization of extracardiac extension is suboptimal
with the use of transthoracic echocardiography for the evaluation of malignant cardiac
masses. Although the use of transesophageal echocardiography overcomes the limited
acoustic window of the transthoracic mode, the airways and lungs can be obstacles for
imaging of the aortic arch, pulmonary arteries and some systemic and pulmonary veins
(3).
MRI is presently the modality of choice to evaluate cardiac tumors. High contrast
resolution and multiplanar capability allow a specific diagnosis and optimal evaluation
of myocardial infiltration, pericardial involvement and extracardiac extension.
Recently, multidetector CT (MDCT) has been increasingly utilized for cardiac imaging.
The short image acquisition time for MDCT is advantageous in cardiac imaging as
compared with the use of MRI. With the use of helical CT, gating the cardiac images to
the electrocardiogram (ECG) can be accomplished either by scanning or reconstructing
raw data at the point of the least cardiac motion (4). The use of ECG-gated MDCT has
better soft tissue contrast than echocardiography and can definitively characterize
fatty content and calcifications. A wide field-of-view with MDCT helps to assess the
extent of a cardiac malignancy and helps to detect metastatic lesions. However, the
Eun Young Kim, MD
1
Yeon Hyeon Choe, MD
1
Kiick Sung, MD
2
Seung Woo Park, MD
3
Ji Hye Kim, MD
1
Young-Hyeh Ko, MD
4
Index terms:
Cardiac tumor
Magnetic resonance (MR)
Multidetector CT
DOI:10.3348/kjr.2009.10.2.164
Korean J Radiol 2009;10:164-175
Received May 2, 2008; accepted 
after revision August 26, 2008.
1Department of Radiology and Center for
Imaging Science; 
2Department of
Thoracic and Cardiovascular Surgery;
3Division of Cardiology, Department of
Medicine; 
4Department of Pathology,
Samsung Medical Center, Sungkyunkwan
University School of Medicine, Seoul 135-
710, Korea
Address reprint requests to:
Yeon Hyeon Choe, MD, Department of
Radiology and Center for Imaging
Science, Samsung Medical Center,
Sungkyunkwan University School of
Medicine, 50 Irwon-dong, Gangnam-gu,
Seoul 135-710, Korea.
Tel. (822) 3410-2509
Fax. (822) 3410-2559
e-mail: yhchoe@skku.edu
Crole of MDCT in the evaluation of cardiac tumors has not
been described adequately in the literature. This article
describes the imaging techniques of the use of MDCT and
MRI for the evaluation of cardiac masses and the imaging
features of benign and malignant cardiac tumors.
Multidetector CT Techniques
Volumetric data of entire hearts were obtained using a
64-slice MDCT scanner (Aquilion 64; Toshiba Medical
Systems, Tokyo, Japan) with the administration of
intravenous contrast material. With the use of a dual-
syringe power injector (Stellant-Dual Flow; Medrad,
Pittsburgh, PA), 65 mL of a nonionic contrast material
(350 mg I/mL iomeprol; Bracco Imaging, Milan, Italy) was
injected at a rate of 4 mL/s. The injection of contrast
material was followed by injection of 30 mL of mixed
normal saline and contrast medium (20% contrast medium
and 80% normal saline) at 3 mL/s. A real time bolus
tracking technique (SureStart; Toshiba Medical Systems,
Tokyo, Japan) was used with a region of interest in the
ascending aorta. A CT scan was started at a threshold
value of 200 Hounsfield units (HU). Imaging was started
from the aortic root to the caudal end of the heart. The CT
scanning parameters were as follows: 120 kV, 400 mA, 64
× 0.5 mm collimation, at pitch values of 0.2-0.3 and a 0.4
second tube rotation time. ECG-gated dose modulation
was applied according to the patient heart rate to reduce
the radiation dose to patients. Raw data were
reconstructed using retrospective ECG gating. The
transverse images were reconstructed with a slice thickness
of 0.4 mm and an image matrix of 512 × 512 pixels. A
display field of 26 cm was sufficient, which corresponded
to a pixel size of approximately 0.5 mm.
MR Imaging Techniques
A cardiac surface coil usually provided good signals with
the use of a 1.5-T scanner (Achieva 1.5 T; Philips Medical
Systems, Best, The Netherlands). Various pulse sequences
were used for imaging cardiac tumors. ECG-gated double
inversion-recovery images (TE = 10 msec), triple inversion-
recovery images (TE = 100 msec), transverse or short-axial
breath-hold cine MR images (balanced turbo field echo
[TFE], TR/TE = 3.1/1.6 msec) were usually obtained before
contrast injection. After injection of contrast material (0.1
mmol/kg at a rate of 2-3 mL/sec; Gd-diethylenetriamine-
pentaacetic acid, Magnevist; Bayer Schering Pharma,
Berlin, Germany), postcontrast images were obtained using
either a double inversion-recovery sequence or delayed
myocardial imaging (TFE, TR/TE = 4.5/1.4 msec) with
suppression of the normal myocardial signals. Three-
dimensional balanced TFE (TR/TE = 4.5/2.2 msec, slice
thickness 2 mm, spacing 1 mm, 144 × 144 matrix) with
respiratory gating was useful in depicting small masses in
the cardiac valves or to detect thrombi. For visualization of
ventricular thrombi, delayed myocardial imaging with a
long inversion time of 400 msec could be used. To evaluate
tumor vascularity, especially in hypervascular tumors such
as hemangiomas, dynamic balanced TFE with sensitivity
encoding was used for perfusion imaging. 
BENIGN TUMORS
Myxomas
Myxomas are the most common benign tumor found in
adults; these tumors present in adulthood between the
fourth and seventh decades (5). The classic triad of
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Table 1. Primary Tumors and Cysts of Heart and
Pericardium
Type Number (%)
Benign
Myxoma 130 (24.2)
Lipoma 045 (8.4)
Papillary fibroelastoma 042 (7.9)
Rhabdomyoma 036 (6.8)
Fibroma 017 (3.2)
Hemangioma 015 (2.8)
Teratoma 014 (2.6)
Mesothelioma of atrioventricular node 012 (2.3)
Granular cell tumor 003
Neurofibroma 003
Lymphangioma 002
Subtotal 319 (59.8)
Pericardial cyst 082 (15.4)
Bronchogenic cyst 007 (1.3)
Subtotal 089 (16.7)
Malignant
Angiosarcoma 039 (7.3)
Rhabdomyosarcoma 026 (4.9) 
Mesothelioma 019 (3.6)
Fibrosarcoma 014 (2.6)
Malignant lymphoma 007 (1.3)
Extraskeletal osteosarcoma 005
Neurogenic sarcoma 004
Malignant teratoma 004
Thymoma 001
Leiomyosarcoma 001
Liposarcoma 001
Synovial sarcoma 001
Subtotal 125 (23.5)
Total 533 (100.0)
Note.─ Adapted from McAllister and Fenoglio (2).symptoms includes cardiac obstructive symptoms related
to the obstruction of blood flow (Fig. 1), embolic events,
and constitutional symptoms such as fever, malaise and
weight loss. Thromboembolic events occur in 35% of left-
sided myxomas to the brain, kidney, spleen and extremi-
ties and 10% of right-sided myxomas to the lung (5-7).
Friable and gelatinous myxomas are more likely to
embolize than firm and fibrous lesions (6). Approximately
75% of myxomas are found in the left atrium, typically, in
the interatrial septum in the region of the fossa ovalis; 20%
of myxomas are located in the right atrium, and rare cases
are found in the ventricles. The use of contrast-enhanced
CT usually demonstrates the presence of a well-defined
spherical or ovoid intracavitary mass, which typically has
lobular contours (Fig. 2). Tumor attenuation is lower than
that of the unopacified blood. The intravenous administra-
tion of a contrast material helps better to define the lesion
as a mass of low attenuation that is surrounded by enhanc-
ing intracardiac blood. Heterogeneity is a common feature
of myxomas and is believed to reflect hemorrhage,
necrosis, cyst formation, fibrosis or calcification. Myxomas
tend to show markedly increased signal intensity as seen
on the T2-weighted MR images (Fig. 3). However,
myxomas can show areas of decreased signal intensity due
to the presence of calcification or magnetic susceptibility
artifacts caused by hemosiderin (8).
Lipomas
Lipomas are the second most common benign cardiac
tumors encountered in adults (5), and these lesions have
specific CT and MR imaging characteristics. The use of CT
shows cardiac lipomas as homogeneous, low-attenuation
masses either in a cardiac chamber or in the pericardial
space (Fig. 4). MR imaging demonstrates lipomas to have
homogeneous increased signal intensity as seen on the T1-
and T2-weighted images that decreases with the use of fat-
saturated sequences. As with soft-tissue lipomas, cardiac
lipomas do not show enhancement with the administration
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Fig. 1. Left atrial myxoma in 38-year-old
female.
A. Reformatted ECG-gated multidetec-
tor CT image in 4-chamber view shows
mass (arrow) in left atrium.
B. Note mass (arrow) extends into left
ventricle during diastolic phase through
mitral valve.
AB
Fig. 2. Left atrial myxoma in 65-year-old
male.
A. Reformatted ECG-gated multidetec-
tor CT image shows left atrial mass
attached to interatrial septum by broad
pedicle (arrows). Note strong contrast
enhancement in part of mass with foci of
calcification (arrowhead).
B. Gross specimen shows myxoid soft
tissue mass with pale yellow and dark
brown colors, which probably represent
mixture of hemorrhage, necrosis, cyst
formation and fibrosis.
ABMultidetector CT and MR Imaging of Cardiac Tumors
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Fig. 4. Right atrial lipoma in 62-year-old
female.
A. ECG-gated multidetector CT image
shows homogeneously low-attenuated
mass with pedicle (arrow) attached to
free wall of right atrium.
B. Gross specimen with cut section
shows fatty nature of mass.
AB
ABC
Fig. 3. Right ventricular myxoma in 30-year-old female.
A. Sagittal double inversion-recovery MR image demonstrates
isointense mass (arrow) occupying right ventricular outflow tract.
B. Sagittal triple inversion-recovery image demonstrates bright
signal intensity in most parts of mass (arrow).
C. Postcontrast double inversion-recovery image demonstrates
hyperenhancement of mass (arrow).
D. Gross specimen demonstrates yellow soft tissue mass with
narrow base of attachment (arrow) to right ventricle.
Dof a contrast material.
Papillary Fibroelastomas
Papillary fibroelastomas are benign endocardial papillo-
mas that mainly affect the cardiac valves and account for
approximately 75% of all cardiac valvular tumors (9).
Papillary fibroelastomas are usually not observed on CT or
MR images as they are small (< 1.5 cm in diameter) and
are attached to the moving valves (9). MR imaging
typically demonstrates the presence of a mass on a valve
leaflet or on the endocardial surface (Fig. 5). These tumors
can create turbulence in the blood flow, which might be
demonstrated with the use of cine MR imaging.
Fibromas
Fibromas are neoplasms that mainly affect infants and
children, being the second most common tumors found in
this age group (10). Grossly, the lesions are solid tumors
that arise within the myocardium and can grow to a size
that obliterates the cavity. The use of CT shows fibromas
as homogeneous masses with soft-tissue attenuation, which
may be either sharply marginated or infiltrative.
Calcification is often observed (Fig. 6A) (10). These tumors
are normally homogeneously isointense to hypointense
relative to the myocardium as seen on T1- and T2-
weighted images due to a dense, fibrous nature. For the
same reason, these tumors often show delayed enhance-
ment on gadolinium-enhanced MR images (Fig. 6B-D)
(11).
Rhabdomyomas
Rhabdomyomas are the most common cardiac tumors in
infancy and childhood, and are often associated with
tuberous sclerosis in up to 50% of cases (12). Most patients
Kim et al.
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Fig. 5. Papillary fibroelastoma of aortic valve in 60-year-old female.
A. ECG-gated multidetector CT image demonstrates abnormal thickening of aortic valve (arrow).
B, C. Oblique cine MR images demonstrates small mass (arrows) attached to aortic valve that was moving according to valvular motion.
D. Oblique transverse triple inversion-recovery MR image demonstrates slightly high signal intensity of small mass (arrow).
E. Surgical specimen shows small mass with many branching frond-like structures.
F. Photomicrograph (Hematoxylin & Eosin staining, ×150) shows fibrous core and scattered smooth muscle cells within papillary projec-
tions.
DEFare asymptomatic, and rhabdomyomas generally regress
spontaneously. These tumors originate within the
myocardium, typically in the ventricles, and multiple
lesions may be present in up to 90% of cases (12).
Rhabdomyomas appear isointense to marginally hyperin-
tense as compared with the myocardium as seen on T1-
Multidetector CT and MR Imaging of Cardiac Tumors
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Fig. 6. Left ventricular fibroma in 48-year-old female.
A. ECG-gated multidetector CT image shows myocardial thickening
(arrows) and spotty calcification (arrowhead) in lateral wall of left
ventricle.
B. Transverse double inversion-recovery MR image shows
hypointense mass (arrows) in myocardium of left ventricle.
C. Transverse triple inversion-recovery MR image also shows
hypointense mass (arrows) in myocardium of left ventricle.
D. Delayed MR image with suppression of normal myocardial signal
10 minutes after administration of gadolinium demonstrates hyperen-
hancement of mass (arrows).
A
Fig. 7. Cardiac rhabdomyoma in newborn with tuberous sclerosis.
A. Gadolinium-enhanced T1-weighted MR image shows abnormal enhancing lesions (arrows) in both caudate nuclei and frontal lobes,
indicating presence of tubers.
B. Sagittal T1-weighted spin echo MR image shows isointense mass (arrows) in septum and anterior wall of left ventricle.
C. Transverse gadolinium-enhanced T1-weighted spin echo MR image shows mild enhancement of mass (arrows).
ABCKim et al.
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weighted images and hyperintense as seen on T2-weighted
images (Fig. 7).
Hemangiomas
Hemangiomas are benign vascular tumors that comprise
approximately 5-10% of benign tumors (5). Cardiac
hemangiomas are heterogeneous as depicted on pre-
contrast CT images and are intensely enhanced as seen on
CT images obtained after the administration of a contrast
material. As with hepatic hemangiomas, these tumors
typically show intermediate signal intensity as seen on T1-
weighted images and become hyperintense as seen on the
T2-weighted images (Fig. 8) (13).
PRIMARY MALIGNANCIES
Angiosarcomas
The most common cardiac sarcomas are angiosarcomas
that comprise 37% of all cases (5). These lesions are
malignant mesenchymal tumors and usually cause right-
sided heart failure or tamponade as the tumors tend to
occur in the right atrium and involve the pericardium.
Presentation is late, and there is often the presence of
metastases at the time of diagnosis, particularly to the lung.
Invasive behavior is a feature of malignant lesions with
pericardial or pleural effusion. The use of CT often shows
the presence of a low-attenuated mass in the right atrium,
which might be irregular or nodular (Fig. 9). Cardiac
sarcomas may have heterogeneous signal intensity as seen
on MR images (Fig. 9), with areas of high signal intensity as
seen on T2-weighted images representing the blood-filled
spaces within the neoplasm. A papillary appearance can be
observed as a specific MR feature of an angiosarcoma, with
a nodular area of high signal intensity interspersed within
areas of intermediate signal intensity as seen on T1- and
T2-weighted images (14). In cases with diffuse pericardial
infiltration, some investigators have described linear
enhancement along the vascular spaces as a “sunray”
Fig. 8. Cavernous hemangioma of left
atrial appendage in 66-year-old female.
A. Transverse double inversion-
recovery MR image shows intermediate
signal intensity mass (arrows) in left
atrial appendage.
B. Transverse triple inversion-recovery
MR image shows hyperintense mass
(arrows) with smooth margin.
C. Coronal gadolinium-enhanced double
inversion-recovery MR image shows
strong enhancement of lesion (arrows).
D. Gross specimen with cut section
demonstrates trabecular, hemorrhagic,
and cystic appearance of mass.
AB
CDappearance (14). 
Other Cardiac Sarcomas
Although angiosarcomas are the most common cardiac
sarcomas, all types of sarcomas, including undifferentiated
sarcomas, malignant fibrous histiocytomas (MFHs),
leiomyosarcomas, osteosarcomas, lymphosarcomas,
myxosarcomas, neurogenic sarcomas, synovial sarcomas,
neurofibrosarcomas, and Kaposi’s sarcomas can affect the
heart. Although most angiosarcomas occur in the right
atrium, the other sarcomas affect the left atrium more
frequently, which is an important differentiating feature
(5).
Malignant fibrous histiocytomas consist of primitive
mesenchymal, fibroblastic, and histiocytic cells arranged in
a storiform pattern (15). The most common location of the
MFHs is the left atrium where the tumors are usually
attached to the posterior wall (Fig. 10) (15). Distinguishing
MFHs from a benign cardiac tumor might be difficult on a
clinical and imaging basis. MR imaging demonstrates the
presence of a MFH as a mass with a nonspecific signal
intensity as seen on T1- and T2-weighted images. A MFH
arises from the posterior wall of the left atrium and can
extend into the pulmonary veins (Fig. 10). This finding
would not normally be expected with a myxoma.
Myxosarcoma is a rare form of primary malignant
tumors that is very difficult to differentiate from a
myxoma (Fig. 11). The ratio between the incidence of
myxomas and myxosarcomas is approximately 100: 0.8
and the prognoses of the two tumor types are very differ-
ent (16). Myxosarcomas have local recurrences, involving
the pulmonary artery, pericardium or pleura and distant
metastases, with the brain being the site most affected
(16).
Primary Cardiac Lymphomas
Primary cardiac lymphomas are extremely rare, with a
reported incidence of 0.15 to 1% (1, 5). A diffuse large B
cell lymphoma is the most common type of primary
cardiac lymphoma encountered. Most cases of cardiac
lymphomas are solid, infiltrative tumors in one or multiple
chambers of the heart. The massive infiltration of
lymphoma cells in the myocardium results in irregular
thickening of the walls of the heart, mimicking classic
hypertrophic cardiomyopathy (HCM) (1, 5). CT images
show cardiac lymphomas as hypo- or iso-attenuated
infiltrative soft tissue masses as compared with the
myocardium, and the masses demonstrate heterogeneous
enhancement after the administration of a contrast agent
(17). With the use of MR imaging, these tumors appear
Multidetector CT and MR Imaging of Cardiac Tumors
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Fig. 9. Angiosarcoma of right atrium in 48-
year-old male.
A. ECG-gated multidetector CT image
shows large mass (arrows) in free wall of
right atrium. Mass shows irregular and
nodular contour and strong contrast
enhancement. 
B. Transverse double inversion-recovery
MR image demonstrates mostly isointense
mass (arrows) in right atrium.
C. Transverse triple inversion-recovery MR
image demonstrates presence of heteroge-
neously hyperintense mass (arrows).
D. Gadolinium-enhanced double inversion-
recovery MR image shows heterogeneous
hyperenhancement of mass. Within mass, some portions (arrows) have no enhancement, representing intratumoral thrombosis. 
E. Gross specimen shows irregular mass (arrows) of right atrium. Mass had multiple intratumoral thrombi.
DEisointense as seen on T1-weighted images and heteroge-
neously hyperintense as seen on T2-weighted images. The
tumors demonstrate heterogeneous enhancement after the
administration of a gadolinium contrast material, with
areas of low enhancement seen in the center of the lesion
as compared with the periphery (Fig. 12) (17).
Metastatic Involvement
Metastases to the heart are much more common than
primary involvement, with an estimated ratio of 30:1 (18).
In the presence of a malignant tumor, cardiac metastases
are encountered in 11% of cases (19). The tumors that
most frequently metastasize to the heart are lung and
breast cancers, melanomas and lymphomas (19).
The epicardium is the site most often affected by
metastases (18, 19). Spread is mainly via a retrograde
route through the mediastinal lymphatics, leading to
implantation in the epicardial surface of the heart. Other
tumors such as melanomas and sarcomas usually spread
hematogenously to the myocardium and epicardium
through the coronary arteries, or less commonly, by the
implantation of cancer cells through the vena cava (Fig. 13)
(19). Hematogenous metastases in the heart and
pericardium are normally accompanied by evidence of
hematogenous metastases in other organs. In particular,
pulmonary metastases are usually present (19).
Direct extension can occur with thymic, bronchial, breast
and esophageal malignancies due to the proximity of the
primary lesions to the heart. In addition, transvenous
tumor spread relies on an extension of the tumor thrombus
into the right atrium through the superior (lung cancers) or
inferior vena cava (tumors from the kidney or liver) or an
extension into the left atrium via the pulmonary veins. The
Kim et al.
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Fig. 10. Malignant fibrous histiocytoma in 57-year-old female.
A. Transverse double inversion-recovery MR image shows large isointense mass (arrows) arising from posterior wall of left atrium that
extends into mitral valve.
B. Transverse triple inversion-recovery MR image shows hyperintense mass (arrows) with irregular contour.
C. Gadolinium-enhanced double inversion-recovery MR image shows heterogeneous hyperenhancement of mass (arrows).
D. ECG-gated multidetector CT reformatted image shows that mitral valve (arrow) is abutting mass. At surgery, mitral valve was found to
be involved by malignant mass. Mass was removed and mitral valve was replaced with artificial valve.
E. Gross specimen shows presence of multilobulated mass. Cut surface was seen with heterogeneous, gelatinous, myxoid, yellowish
white and hemorrhagic appearance (not shown).
DEenhancement patterns after the administration of gadolin-
ium might be helpful to differentiate a thrombus from a
combined tumor. Tumors would be expected to show
heterogeneous enhancement whereas thrombi should not.
Limitations of the Use of Multidetector CT and MRI
and Various Pitfalls in the Imaging Evaluation of
Cardiac Tumors
The disadvantages of the use of MDCT include radiation
exposure to the patient and the need to administer
potentially nephrotoxic contrast material. Streak artifacts
can occur when the contrast material remains in the right
Multidetector CT and MR Imaging of Cardiac Tumors
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Fig. 11. Left atrial myxosarcoma in 72-year-old female.
A. Reformatted ECG-gated multidetector CT image shows irregular
mass (arrow) with broad-base attachment to left atrium. Also, note
minimal wall thickening (arrowheads) of interatrial septum due to tumor
spread along left atrial wall and septum.
B. Oblique double inversion-recovery MR image depicts hyperintense
lesion (arrow) after gadolinium injection.
C. Virtual angioscopic multidetector CT image shows irregular mass
(arrow) near mitral valve (MV) and small polypoid mass (arrowhead).
D. At surgery, presence of lobulated soft tissue mass (arrow) and small
polypoid lesions were demonstrated (arrowheads).
D
Fig. 12. Primary cardiac lymphoma
(diffuse large B-cell type) in 73-year-old
male.
A. Non-gated postcontrast multidetector
CT image shows homogeneous and
mildly hyperattenuated mass (arrows) in
right atrial wall and interatrial septum.
Mass is spreading along pericardial
space. Pericardial effusion (asterisk) is
probably due to pericardial invasion.
B. Coronal gadolinium-enhanced double
inversion-recovery MR image shows
presence of diffuse infiltrative mass
(arrows) in right atrium. Mass shows
homogeneous enhancement that distin-
guishes it from pericardial effusion
(asterisk). ABheart during image acquisition. In this case, the use of a
delayed scan or split-bolus injection (for example, 65 mL
at 4 mL/sec followed by 30 mL at 1 mL/sec) or the
administration of a contrast-saline mixture (80% and 20%,
respectively) instead of an injection of saline only after
contrast injection can eliminate streak artifacts and can
visualize the right atrial masses. Disadvantages of the use
of MRI include a long scan time and the inability to
demonstrate calcification and small masses, especially in
cardiac valves due to limited spatial resolution (20).
Some benign conditions such as lipomatous hypertrophy,
mass-like hypertrophy of the left ventricular myocardium,
prominent crista terminalis, and thrombi can mimic a
cardiac tumor. Lipomatous hypertrophy of the interatrial
septum is a benign condition that is characterized by fat
accumulation in the interatrial septum. It results from
adipose-cell hyperplasia and is related to advanced age and
obesity (21). The tissue appears as a wedge-shape or
diffuse septal thickening on CT and MR images with signal
intensity comparable to that of subcutaneous fat as seen on
T1- and T2-weighed MR images (22). Mass-like hypertro-
phy of the left ventricular myocardium may mimic cardiac
tumors (23). However, mass-like HCM has more homoge-
neous signal characteristics and perfusion of the lesion is
similar to the signal characteristics of the adjacent normal
myocardium, except in the areas of fibrosis, whereas
tumors often show varying degrees of signal heterogeneity
before and after gadolinium administration. In addition,
HCM will show variable degrees of contractility whereas a
true mass will have no contractile portion (23). The line of
union between the right atrium and the right auricle is
present on the interior of the atrium in the form of a
vertical crest, known as the crista terminalis. Regression of
the crista terminalis is known to occur to variable degrees;
thus, widely variable prominence exhibited by this
structure is seen (24, 25). A prominent crista terminalis can
be misinterpreted as a right atrial mass, especially when
echocardiography is used as an isolated imaging technique
for the heart. MRI will prevent misinterpretation of the
presence of normal intracardiac structures by the accurate
identification of the exact position and extension of
fibromuscular prominent structures to distinguish the
structures from a neoplasm or thrombus (25). A thrombus
is most likely to be located posterior in the left atrium. The
signal intensity characteristics of a thrombus vary with MR
imaging and are dependent on the age of the thrombus. An
acute thrombus will appear bright as seen on both T1- and
T2-weighted MR images, whereas a subacute thrombus
will appear bright as seen on T1-weighted images with
hypointense areas seen on T2-weighted images due to the
paramagnetic effects of methemoglobin and shortening of
the T2 relaxation times. A chronic organized thrombus will
exhibit hypointensity as seen on both T1- and T2-weighted
images due to a depleted water content (20). Gadolinium
contrast material is also useful in differentiating a thrombus
from a tumor, as the thrombus should not show enhance-
ment whereas a tumor usually shows enhancement (26).
However, an organized thrombus may show some surface
enhancement.
Kim et al.
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Fig. 13. Hematogenous cardiac
metastases from hepatocellular carcino-
mas in 50-year-old male.
A. ECG-gated multidetector CT image
shows marked thickening of right
ventricular free wall (arrows).
B. Gadolinium-enhanced transverse
double inversion-recovery MR image
shows diffuse thickening of right ventric-
ular wall (arrows).
C, D. Arterial (C) and delayed (D) CT
images show multiple hepatocellular
carcinomas with characteristic dynamic
pattern of early enhancement and wash
out (arrows).
AB
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CONCLUSION
Multidetector CT and MRI may be useful in the differen-
tiation of benign and malignant cardiac masses. MDCT is
useful for the evaluation of calcification and fat content
within a mass and the high spatial resolution of MDCT is
beneficial to define small lesions. MDCT is useful in the
staging of malignant tumors. The excellent contrast resolu-
tion with the use of MRI allows characterization of
fibromas and hemangiomas. Homogeneity of a mass due to
compact cellularity may be characteristic of a lymphoma.
Acquisition of postcontrast sequences enables better
depiction of tumor vascularity and can be used to define
tumor borders. MRI has an important role in differentiating
thrombi from cardiac tumors. Besides the characteristics of
a tumor, a preoperative imaging assessment of cardiac
tumors using MDCT and MRI might help determine
resectability of a tumor and allow planning for reconstruc-
tion of the cardiac chambers.
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